Cargando…
Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases
Patients with rheumatic diseases have an increased risk of mortality by cardiovascular events. In fact, several rheumatic diseases such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and ankylosing spondylitis are associated with a higher prevalence of cardiovascular diseases...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403095/ https://www.ncbi.nlm.nih.gov/pubmed/22910888 http://dx.doi.org/10.1155/2012/125458 |
_version_ | 1782238840357912576 |
---|---|
author | Scotece, Morena Conde, Javier Gómez, Rodolfo López, Verónica Pino, Jesús González, Antonio Lago, Francisca Gómez-Reino, Juan J. Gualillo, Oreste |
author_facet | Scotece, Morena Conde, Javier Gómez, Rodolfo López, Verónica Pino, Jesús González, Antonio Lago, Francisca Gómez-Reino, Juan J. Gualillo, Oreste |
author_sort | Scotece, Morena |
collection | PubMed |
description | Patients with rheumatic diseases have an increased risk of mortality by cardiovascular events. In fact, several rheumatic diseases such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and ankylosing spondylitis are associated with a higher prevalence of cardiovascular diseases (CVDs). Although traditional cardiovascular risk factors have been involved in the pathogenesis of cardiovascular diseases in rheumatic patients, these alterations do not completely explain the enhanced cardiovascular risk in this population. Obesity and its pathologic alteration of fat mass and dysfunction, due to an altered pattern of secretion of proinflammatory adipokines, could be one of the links between cardiovascular and rheumatic diseases. Indeed, the incidence of CVDs is augmented in obese individuals with rheumatic disorders. Thus, in this paper we explore in detail the relationships among adipokines, rheumatic diseases, and cardiovascular complications by giving to the reader a holistic vision and several suggestions for future perspectives and potential clinical implications. |
format | Online Article Text |
id | pubmed-3403095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34030952012-07-30 Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases Scotece, Morena Conde, Javier Gómez, Rodolfo López, Verónica Pino, Jesús González, Antonio Lago, Francisca Gómez-Reino, Juan J. Gualillo, Oreste Mediators Inflamm Review Article Patients with rheumatic diseases have an increased risk of mortality by cardiovascular events. In fact, several rheumatic diseases such as rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and ankylosing spondylitis are associated with a higher prevalence of cardiovascular diseases (CVDs). Although traditional cardiovascular risk factors have been involved in the pathogenesis of cardiovascular diseases in rheumatic patients, these alterations do not completely explain the enhanced cardiovascular risk in this population. Obesity and its pathologic alteration of fat mass and dysfunction, due to an altered pattern of secretion of proinflammatory adipokines, could be one of the links between cardiovascular and rheumatic diseases. Indeed, the incidence of CVDs is augmented in obese individuals with rheumatic disorders. Thus, in this paper we explore in detail the relationships among adipokines, rheumatic diseases, and cardiovascular complications by giving to the reader a holistic vision and several suggestions for future perspectives and potential clinical implications. Hindawi Publishing Corporation 2012 2012-07-15 /pmc/articles/PMC3403095/ /pubmed/22910888 http://dx.doi.org/10.1155/2012/125458 Text en Copyright © 2012 Morena Scotece et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Scotece, Morena Conde, Javier Gómez, Rodolfo López, Verónica Pino, Jesús González, Antonio Lago, Francisca Gómez-Reino, Juan J. Gualillo, Oreste Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases |
title | Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases |
title_full | Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases |
title_fullStr | Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases |
title_full_unstemmed | Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases |
title_short | Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases |
title_sort | role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403095/ https://www.ncbi.nlm.nih.gov/pubmed/22910888 http://dx.doi.org/10.1155/2012/125458 |
work_keys_str_mv | AT scotecemorena roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT condejavier roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT gomezrodolfo roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT lopezveronica roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT pinojesus roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT gonzalezantonio roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT lagofrancisca roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT gomezreinojuanj roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases AT gualillooreste roleofadipokinesinatherosclerosisinterferenceswithcardiovascularcomplicationsinrheumaticdiseases |